Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 31, 1620-1626, November 1, 1971]
© 1971 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wolpert, M. K.
Right arrow Articles by Sartorelli, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wolpert, M. K.
Right arrow Articles by Sartorelli, A. C.

The Role of Phosphohydrolases in the Mechanism of Resistance of Neoplastic Cells to 6-Thiopurines1

M. K. Wolpert, S. P. Damle2, J. E. Brown3, E. Sznycer, K. C. Agrawal and A. C. Sartorelli

Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06510

Phosphohydrolase activity was examined in cell-free extracts of Sarcoma 180 and a subline (Sarcoma 180/TG) resistant to both 6-mercaptopurine and 6-thioguanine as well as their respective nucleosides. Acid phosphohydrolase and soluble 5'-nucleotidase activities were identical in the two cell lines, whereas alkaline phosphohydrolase activity was 8 times greater in Sarcoma 180/TG. Alkaline phosphohydrolase activity was localized predominantly in particulate fractions from Sarcoma 180/TG, showed a pH optimum of 9.2, and hydrolyzed a wide variety of phosphate esters, including p-nitrophenylphosphate and 5'-nucleotides, such as 6-thioinosine 5'-phosphate. It is suggested that enhanced breakdown of the active nucleotide form of the 6-thiopurines by alkaline phosphohydrolase is at least partially responsible for the insensitivity of Sarcoma 180/TG to these agents.

1 This study was supported by Grant CA-02817 from the National Cancer Institute, USPHS, and Grant T-23 from the American Cancer Society.

2 Present address: Departments of Oral Biology and Pharmacology, School of Dentistry, The University of Michigan, Ann Arbor, Mich. 48104.

3 Present address: Department of Medicine, University of Washington School of Medicine, Seattle, Wash. 98125.

Received 5/28/71. Accepted 6/30/71.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1971 by the American Association for Cancer Research.